About the Journal

Journal of Clinical Psychopharmacology, a leading publication in psychopharmacology, offers a wide range of articles reporting on clinical trials and studies, side effects, drug interactions, overdose management, pharmacogenetics, pharmacokinetics, and psychiatric effects of non-psychiatric drugs. The journal keeps clinician-scientists and trainees up-to-date on the latest clinical developments in psychopharmacologic agents, presenting the extensive coverage needed to keep up with every development in this fast-growing field.

Publication & Editorial Staff Contacts


Senior Publisher
Marianne Kerr
Marianne.Kerr@wolterskluwer.com 

Marketing Manager
Rany Aing
Rany.Aing@wolterskluwer.com

Product Advertising
Hilary Druker
609-304-9187 | hilary.druker@wolterskluwer.com

Production Editor
Sara Cleary
sara.cleary@wolterskluwer.com

For Translation approval, License to republish and distribute, or Permission to reuse material in another publication or presentation, please email one of the following:
TranslationRights@wolterskluwer.com
HealthLicensing@wolterskluwer.com
HealthPermissions@wolterskluwer.com

LWW Business Offices 
Two Commerce Square
2001 Market Streeet
Philadelphia, PA 19103
Phone:215-521-8300
www.lww.com

Editors-in-Chief
Richard I. Shader, MD
Journal of Clinical Psychopharmacology
Tufts University School of Medicine
Dept of Pharmacology and Experimental Therapeutics
136 Harrison Ave
Boston, MA 02111
Phone: 617-636-2178

David J. Greenblatt, MD
Journal of Clinical Psychopharmacology
Tufts University School of Medicine
Dept of Pharmacology and Experimental Therapeutics
136 Harrison Ave
Boston, MA 02111
Phone: 617-636-2178

Managing Editor
Barbara Kern
Barbara.kern@tufts.edu